-
10010312-25An inhibitor of EGF receptor kinase with an IC50 value of 3 µM in the human epidermoid carcinoma cell line A431.
-
10010312-5An inhibitor of EGF receptor kinase with an IC50 value of 3 µM in the human epidermoid carcinoma cell line A431.
-
10010312-50An inhibitor of EGF receptor kinase with an IC50 value of 3 µM in the human epidermoid carcinoma cell line A431.
-
10010243-1A selective ATP-competitive inhibitor of the tyrosine kinase activity of HER2/neu (IC50 = 0.35 µM).
-
10010243-10A selective ATP-competitive inhibitor of the tyrosine kinase activity of HER2/neu (IC50 = 0.35 µM).
-
10010243-5A selective ATP-competitive inhibitor of the tyrosine kinase activity of HER2/neu (IC50 = 0.35 µM).
-
10010243-50A selective ATP-competitive inhibitor of the tyrosine kinase activity of HER2/neu (IC50 = 0.35 µM).
-
10793-10A tyrphostin compound that inhibits nerve growth factor (NGF)-dependent TrkA tyrosine phosphorylation in PC-12 cells (IC50 = ~40&muM), HER2-ErbB2 kinase in several breast and ovarian cancer cell lines (IC50 = ~0.5 &muM), and the VEGF receptor FLK1
-
10793-25A tyrphostin compound that inhibits nerve growth factor (NGF)-dependent TrkA tyrosine phosphorylation in PC-12 cells (IC50 = ~40&muM), HER2-ErbB2 kinase in several breast and ovarian cancer cell lines (IC50 = ~0.5 &muM), and the VEGF receptor FLK1
-
10793-5A tyrphostin compound that inhibits nerve growth factor (NGF)-dependent TrkA tyrosine phosphorylation in PC-12 cells (IC50 = ~40&muM), HER2-ErbB2 kinase in several breast and ovarian cancer cell lines (IC50 = ~0.5 &muM), and the VEGF receptor FLK1
-
10793-50A tyrphostin compound that inhibits nerve growth factor (NGF)-dependent TrkA tyrosine phosphorylation in PC-12 cells (IC50 = ~40&muM), HER2-ErbB2 kinase in several breast and ovarian cancer cell lines (IC50 = ~0.5 &muM), and the VEGF receptor FLK1
-
10010313-10AG-99 is an inhibitor of EGF receptor kinase with an IC50 value of 10 µM in the human epidermoid carcinoma cell line A431.